Tag: Generic Medicines
Momentis Surgical’s Anovo Robotic System Gets FDA Approval for Multiport Surgery
Momentis Surgical has secured 510(k) clearance from the U.S. Food and Drug Administration for a multiport version of its Anovo Surgical System, the company announced July 23...
Pharma Regulatory Framework Faces New Scrutiny Over Rising Use of Brand Name Extensions
In a critical move toward sharpening drug safety and regulatory clarity, the misuse and proliferation of "brand name extensions" within the pharmaceutical sector has...
FDA Reaches Out to Indian Pharma Amid Critical Ifosfamide Shortage in U.S.
A chemotherapy drug that stands between cancer patients and their treatment has gone dangerously scarce in the United States, compelling federal health regulators to...
Glenmark Launches Generic Methylene Blue Injection in the U.S.
Glenmark Pharmaceuticals Inc., USA (Glenmark) announced the official launch of Methylene Blue Injection USP, 50 mg/10 mL (5 mg/mL) Single-Dose Vial. Glenmark’s new generic...
12 Years, One Mission: Affordable Medicines and a Stronger Pharma Future for India
India’s pharmaceutical sector has witnessed remarkable growth over the past 12 years, driven by initiatives aimed at expanding healthcare access, strengthening domestic manufacturing, and...
The FDA has outlined its updated strategy for generic drug oversight
The U.S. Food and Drug Administration (FDA) announced its modernized framework for generic drug oversight, highlighting a dual focus on enforcing rigorous quality standards...